Talley announce the latest independent TECare™ laboratory test results

Posted: Friday, March 28th, 2008

Hospital Infection Research Laboratory, Birmingham, UK have conducted EN1276 quantitative suspension efficacy testing on TECare™ antimicrobial fluid using four organisms; Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Enterococcus hirae.

To pass this test a greater than 5 Log10 reduction in test bacteria is required within 5 minutes. TECare achieved greater reductions in bacterial load than was required within 1 minute in both clean and dirty conditions.

Neil Manser, Business Development Manager for Talley Environmental Care commented ‘These fantastic results validate the extensive independent testing already carried out on TECare. The dramatic reduction in the level of bacteria present after treatment demonstrates the efficacy of the product range and reconfirms its importance in the decontamination of sensitive medical equipment and clinical environments’.

TECare is a safe, effective broad spectrum high level antimicrobial product that coats hard and soft surfaces, inhibiting microbial growth for up to 4 weeks without damaging the treated material. A range of TECare products are available from wipes to 20 litre drums and they currently being used by NHS and private healthcare facilities across the UK.

The Talley group uses and recommends TECare for the cleaning and decontamination of its entire medical range including Venturi™ wound therapy and Quattro™ alternating pressure reliving mattresses.